Scholarlink

<p>Electroporation-based therapies are established non-thermal ablation strategies for targeted tissue destruction. Here, a custom high-voltage pulse generator and a parallel-plate electrode system were used to deliver the irreversible electroporation (IRE), electrochemotherapy (ECT), and IRE-BLM protocols to rabbit VX2 liver tumors. The parallel-plate configuration was designed to provide a more homogeneous electric field across the target volume while avoiding direct puncture of the hepatic parenchyma by the electrodes. IRE, bleomycin-based ECT, and IRE–bleomycin therapy were evaluated at 1, 8, and 21 days after treatment using histopathology and immunohistochemistry, including p53 and Ki-67 analysis. IRE and ECT monotherapies induced marked acute tissue injury but did not prevent substantial tumor regrowth by 8 days after treatment. In contrast, the IRE-BLM protocol produced the greatest reduction in viable tumor burden, delayed tumor regrowth, and showed a 95.5% reduction in tumor volume relative to the long-term tumor control group, although residual viable tumor cells were detected at late follow-up. By day 21 after treatment, treated hepatic tissue showed an organized reparative response, with progressive remodeling of the ablated area and fibrous tissue deposition. These findings support further investigation of electroporation-based combination strategies and highlight the value of time-course follow-up in aggressive tumor models.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Time-course evaluation of irreversible electroporation, bleomycin electrochemotherapy, and IRE–bleomycin therapy in a rabbit VX2 liver model using a high-voltage generator

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月27日

查看全文
  • B. López-Alonso,
  • P. Briz,
  • J. Aramayona,
  • O. Lucía,
  • H. Sarnago,
  • M. D. Arribas,
  • M. Malo-Urriés,
  • J. M. Burdío,
  • A. Güemes,
  • E. Monleón

摘要

Electroporation-based therapies are established non-thermal ablation strategies for targeted tissue destruction. Here, a custom high-voltage pulse generator and a parallel-plate electrode system were used to deliver the irreversible electroporation (IRE), electrochemotherapy (ECT), and IRE-BLM protocols to rabbit VX2 liver tumors. The parallel-plate configuration was designed to provide a more homogeneous electric field across the target volume while avoiding direct puncture of the hepatic parenchyma by the electrodes. IRE, bleomycin-based ECT, and IRE–bleomycin therapy were evaluated at 1, 8, and 21 days after treatment using histopathology and immunohistochemistry, including p53 and Ki-67 analysis. IRE and ECT monotherapies induced marked acute tissue injury but did not prevent substantial tumor regrowth by 8 days after treatment. In contrast, the IRE-BLM protocol produced the greatest reduction in viable tumor burden, delayed tumor regrowth, and showed a 95.5% reduction in tumor volume relative to the long-term tumor control group, although residual viable tumor cells were detected at late follow-up. By day 21 after treatment, treated hepatic tissue showed an organized reparative response, with progressive remodeling of the ablated area and fibrous tissue deposition. These findings support further investigation of electroporation-based combination strategies and highlight the value of time-course follow-up in aggressive tumor models.